CEO of Aerie Pharmaceuticals Inc (AERI, Financial) Vicente Jr Anido sold 150,000 shares of AERI on 06/08/2018 at an average price of $62.28 a share. The total sale was $9.3 million.
Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie Pharmaceuticals Inc has a market cap of $2.5 billion; its shares were traded at around $63.25 .
CEO Recent Trades:
- CEO Vicente Jr Anido sold 150,000 shares of AERI stock on 06/08/2018 at the average price of $62.28. The price of the stock has increased by 1.56% since.
Directors and Officers Recent Trades:
- Director Gerald D. Cagle bought 1,000 shares of AERI stock on 05/25/2018 at the average price of $49.45. The price of the stock has increased by 27.91% since.
- Director Gerald D. Cagle bought 1,000 shares of AERI stock on 05/21/2018 at the average price of $50.25. The price of the stock has increased by 25.87% since.
- Chief Scientific Officer Casey C. Kopczynski sold 11,000 shares of AERI stock on 06/06/2018 at the average price of $58.75. The price of the stock has increased by 7.66% since.
- Chief Scientific Officer Casey C. Kopczynski sold 2,708 shares of AERI stock on 05/29/2018 at the average price of $50.15. The price of the stock has increased by 26.12% since.
For the complete insider trading history of AERI, click here
.
